-
effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
October 01, 2007 - Subjects were censored on the occurrence of death, disenroll-
ment, discontinuity of enrollment, or July … Prevention of cardiovascular events and death
with pravastatin in patients with coronary heart disease
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
March 10, 2010 - We felt that cardiovascular mortality (which included death from vascular
causes such as stroke) was … an inherently different endpoint than cardiac
death which justified them being assessed separately.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
December 01, 2011 - ventricular systolic
dysfunction, and an increased risk of a
major adverse cardiovascular event
(MACE) or death … found that use of
catheter aspiration, age, and symptom to balloon time
were significant predictors of cardiac … death (no deaths
were of noncardiac cause) at 2 years. … Cardiac
death and reinfarction after 1 year in the Thrombus
Aspiration during Percutaneous coronary intervention … death.
-
effectivehealthcare.ahrq.gov/products/renal-cancer/clinician
July 18, 2017 - Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence
Clinician Summary Archived July 18, 2017 Download Main Document PDF 897.3 KB
Archived: This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current. …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
July 01, 2017 - Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence
Management of Renal Masses and Localized Renal Cell
Carcinoma: Current State of the Evidence
Focus of This Summary
This is a summary of a systematic review that evaluated the recent evidence regarding the benefits and adve…
-
effectivehealthcare.ahrq.gov/products/substance-use-disorders-adolescents/protocol
October 29, 2018 - and physical health problems. 7 Adolescent substance use is associated with the leading causes of death … opiates (e.g., heroin), have brought heightened attention to the significant risk of drug overdose death
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-disposition-comments.pdf
October 29, 2021 - interpretation of LCA and
k-means outputs, and demonstrates significant differences in 1-year outcomes (death
-
effectivehealthcare.ahrq.gov/sites/default/files/malnutrition-hospitalized-adults-draft-appendixes.pdf
April 08, 2021 - Events
Bonilla-
Palomas
et al. 201645
1-month mortality,
%:
Tx: 0.07; CG: 0.11,
p=NR
3-month death … from
any cause, %:
Tx: 0.14; CG: 0.26,
p=NR
6-month death from
any cause, %:
Tx: 0.15; CG: … 0.36,
p=NR
12-month death
from any cause, %:
Tx: 0.203; CG:
0.475, p=0.003
NR 1-month
readmission … CG:
8.7%, p=0.020
90-day mortality,
%:
ONS: 4.8%; CG:
9.7%, p=0.018
The NNT to
prevent 1 death
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-summary.pdf
September 01, 2020 - frequently diagnosed cancers among U.S. men (191,930 new cases) and the second leading cause
of cancer death
-
effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
September 01, 2020 - frequently diagnosed cancers among U.S. men (191,930 new cases) and the second leading cause
of cancer death
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
December 01, 2009 - Layout 1
Background
Breast cancer is the second most common
malignancy of women, with over 180,000
new cases diagnosed each year in the
United States. Survival rates depend on the
stage of disease at diagnosis. Women
diagnosed with early stages of breast
cancer have a 5-year survival rate near 100
percent. However, …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
November 01, 2014 - lengths of
stay and costs of care; in one report from Asian countries,
they were associated with death … ventilation
1 prospective
cohort (n=638)
High NA Direct Imprecise Insufficient
Mortality
(composite
of death … response or days
on a ventilator—or preferably, patient-centered health
outcomes, especially disease or death
-
effectivehealthcare.ahrq.gov/products/alcohol-misuse/research-protocol
July 22, 2011 - Actual causes of death in the United States, 2000. JAMA 2004 Mar 10;291(10):1238-45.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
November 20, 2013 - This SHFM predicts mode of
death given clinical, diagnostic and laboratory data for
ambulatory patients … protein, N-
terminal proBNP, and cardiac troponin T and I in end stage
renal disease for subsequent death … The Protect study was not included as it was unclear
whether the reported of death as cardiovascular … death
included all deaths.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - therapy had greater
increases in their HDL-c, there were no benefits on incidence of cardiovascular
death … IMPROVE-IT trial will compare ezetimibe added to simvastatin to simvastatin
monotherapy on cardiovascular death … superior lipid outcomes, but fails to reduce
atherosclerosis or lead to decreased rates of cardiovascular death … lipid outcomes, but fails to reduce atherosclerosis or lead to decreased rates of
cardiovascular death … therapy can lead to superior lipid
outcomes, but fail to reduce clinical outcomes such as cardiovascular death
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
April 01, 2020 - Pregabalin and the risk for opioid-related death: a
nested case-control study. … Gabapentin,
opioids, and the risk of opioid-related death: A
population-based nested case-control study
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/genitourinary-syndrome-key-questions.pdf
January 01, 2021 - Systemic adverse events: chronic pain, CVA (stroke); VTE (DVT); death; hot
flashes; headache; breast
-
effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
March 01, 2011 - CAD causes
one in six deaths in the United States
and is the leading cause of death
globally.1 … life
• Revascularization
• Change in angina
• Myocardial infarction
• Heart failure
• Stroke
• Death … For
studies of predictive accuracy, only hard clinical outcomes
(i.e., MI, death, composite cardiac … No major complications were
attributed to the imaging procedure; 30-day death, MI, and
stroke were … echocardiography with exercise
ECG; this trial reported similar frequency of a composite
outcome that included cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
February 01, 2006 - Layout 1
Background
Breast cancer is the second most common
malignancy in women. The American
Cancer Society estimated that in the United
States in 2005, 212,930 women would be
newly diagnosed as having breast cancer
and there would be 40,870 deaths due to
this disease. Because early breast cancer is
asymptomatic, th…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-221-copd-evidence-summary.pdf
October 01, 2019 - diseases, of which COPD is the largest
contributing condition, are the fourth
leading cause of death … Patients hospitalized with COPD exacerbations are
at high risk for hospital readmissions and death